+Search query
-Structure paper
| Title | Lead compounds for the development of SARS-CoV-2 3CL protease inhibitors. |
|---|---|
| Journal, issue, pages | Nat Commun, Vol. 12, Page 2016-2016, Year 2021 |
| Publish date | Aug 16, 2020 (structure data deposition date) |
Authors | Iketani, S. / Forouhar, F. / Liu, H. / Hong, S.J. / Lin, F.Y. / Nair, M.S. / Zask, A. / Huang, Y. / Xing, L. / Stockwell, B.R. ...Iketani, S. / Forouhar, F. / Liu, H. / Hong, S.J. / Lin, F.Y. / Nair, M.S. / Zask, A. / Huang, Y. / Xing, L. / Stockwell, B.R. / Chavez, A. / Ho, D.D. |
External links | Nat Commun / PubMed:33795671 |
| Methods | X-ray diffraction |
| Resolution | 1.73 - 1.94 Å |
| Structure data | ![]() PDB-7jst: ![]() PDB-7jsu: ![]() PDB-7jt0: ![]() PDB-7jt7: ![]() PDB-7jw8: |
| Chemicals | ![]() ChemComp-PO4: ![]() ChemComp-HOH: ![]() ChemComp-UED: ![]() ChemComp-LW1: ![]() ChemComp-TG3: ![]() ChemComp-BTB: |
| Source |
|
Keywords | VIRAL PROTEIN / HYDROLASE / 3CL Main Protease / HYDROLASE/INHIBITOR / SARS-CoV-2 3CL protease / HYDROLASE-INHIBITOR complex |
Movie
Controller
Structure viewers
About Yorodumi Papers



Authors
External links











Keywords